Interests
Carlos Coronel, PhD
Neuroscientist
To reduce the scale and impact of dementia, we need to promote collaborative efforts and develop novel and affordable biomarkers for underserved and underrepresented populations.
Current Work
Carlos is a postdoctoral researcher at the Latin American Brain Health Institute (BrainLat), Chile. He is researching new biomarkers using electroencephalography and mathematical models.
Personal Hero
Tuomas Holopainen
Words of Strength
Lead, encourage, empower, create, inspire
Vision
Carlos believes that to reduce the scale and impact of dementia, we need to promote collaborative efforts, and develop novel and affordable biomarkers for underserved and underrepresented populations.
Strategy
Carlos is using mathematical models and electroencephalography to identify possible biomarkers of dementia. This can help in the development of novel therapeutic targets for neurodegenerative diseases.
Impact
As an Atlantic Fellow, Carlos aims to gain a deeper understanding of socioeconomic and biological risk factors of dementia. He wants to boost neuroscience research in Latin America, and reduce the impact of dementia in the region.
Motivation
Dementia is facing rapid growth in Latin America, a highly diverse region underrepresented in dementia research. Region-specific and robust biomarkers are critical to provide a precise and early diagnosis of dementia.
Education & Experience
Carlos holds a bachelor's degree in Biology (Universidad de Carabobo, Venezuela), and a PhD in Biophysics and Computational Biology (Universidad de Valparaíso, Chile). He is currently working as a postdoctoral researcher at the BrainLat Institute (Universidad Adolfo Ibáñez, Chile).
Send
Carlos
a NoteHave ideas for global brain health or a collaboration? I would love to hear from you. Feel free to send an introductory note.
